News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
Gilead Wales experts back HIV prophlyaxis, ahead of key meetings Cost-effectiveness bodies in Wales and Scotland to decide on Truvada in April.
News Government must rethink drug rationing plans - experts The government looks set to come under pressure to rethink moves to ration access to medicines, after a new plan from NICE and NHS England was criticised by industry representatives and oth
News Pharma attacks plan to ration new drugs in England Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.
News NICE rejects Opdivo in blood cancer, asks for more data Merck's rival Keytruda gets new US indication.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
